Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in NVCT — Nuvectis Pharma, Inc.

CIK 70858 CHARLOTTE, NC
Back to NVCT Full portfolio

Position in NVCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$218,289
+$103,522 QoQ
Shares Held
11,870
-20.1% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 82 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. NVCT ranks #284 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in NVCT

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $218,289 11,870
2026-03-31 $114,767 14,847
2025-12-31 $101,697 13,470
2025-09-30 $48,412 8,042
2025-06-30 $63,979 8,565
2025-03-31 $16,178 1,656
2024-12-31 $8,736 1,615
2024-09-30 $4,779 760
2024-06-30 $4,835 764
2024-03-31 $30,954 3,775
2023-12-31 $62,590 7,505
2023-09-30 $79,118 6,138
2023-06-30 $21,655 1,356
2023-03-31 $2,150 164
2022-12-31 $90 12